Your browser doesn't support javascript.
loading
Idiopathic anaphylaxis yardstick: Practical recommendations for clinical practice.
Carter, Melody C; Akin, Cem; Castells, Mariana C; Scott, Erin P; Lieberman, Phil.
Afiliação
  • Carter MC; National Institutes of Health, Bethesda, Maryland.
  • Akin C; Department of Medicine, University of Michigan, Ann Arbor, Michigan.
  • Castells MC; Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Mastocytosis Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Scott EP; Scott Medical Communications, LLC, Tyler, Texas.
  • Lieberman P; Departments of Medicine and Pediatrics, Divisions of Allergy and Immunology, University of Tennessee, Memphis, Tennessee. Electronic address: phillieberman@hotmail.com.
Ann Allergy Asthma Immunol ; 124(1): 16-27, 2020 01.
Article em En | MEDLINE | ID: mdl-31513910
ABSTRACT
Anaphylaxis is considered idiopathic when there is no known trigger. The signs and symptoms of idiopathic anaphylaxis (IA) are identical to those of anaphylaxis because of a known cause and can include cutaneous, circulatory, respiratory, gastrointestinal, and neurologic symptoms. Idiopathic anaphylaxis can be a frustrating disease for patients and health care providers. Episodes are unpredictable, and differential diagnosis is challenging. Current anaphylaxis guidelines have little specific guidance regarding differential diagnosis and long-term management of IA. Therefore, the objective of the Idiopathic Anaphylaxis Yardstick is to use published data and the authors' combined clinical experience to provide practical recommendations for the diagnosis and management of patients with IA.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epinefrina / Anafilaxia Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Ann Allergy Asthma Immunol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epinefrina / Anafilaxia Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Ann Allergy Asthma Immunol Ano de publicação: 2020 Tipo de documento: Article